Phase I Trial of Taxol as a Radiation Sensitizer with Cisplatin in Advanced Cervical Cancer
- 30 November 1997
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 67 (2) , 131-136
- https://doi.org/10.1006/gyno.1997.4851
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell linesCancer, 1996
- Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.Journal of Clinical Oncology, 1996
- In Vitro Studies of Taxol as a Radiation Sensitizer in Human Tumor CellsJNCI Journal of the National Cancer Institute, 1994
- Taxol: A New Drug with Significant Activity as a Salvage Therapy in Advanced Epithelial Ovarian CarcinomaGynecologic Oncology, 1993
- Taxol Sensitizes Human Ovarian Cancer Cells to RadiationGynecologic Oncology, 1993
- Taxol: A novel radiation sensitizerInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI Journal of the National Cancer Institute, 1990
- A phase II trial of taxol in metastatic melanomaCancer, 1990
- Taxol stabilizes microtubules in mouse fibroblast cells.Proceedings of the National Academy of Sciences, 1980